These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Comparison of clinical outcomes after transcarotid and transsubclavian versus transfemoral transcatheter aortic valve implantation: A propensity-matched analysis. Villecourt A; Faroux L; Muneaux A; Tassan-Mangina S; Heroguelle V; Poncet A; Nazeyrollas P; Ruggieri VG; Metz D Arch Cardiovasc Dis; 2020 Mar; 113(3):189-198. PubMed ID: 32037133 [TBL] [Abstract][Full Text] [Related]
26. Clinical outcome and paravalvular leakage of the new balloon-expandable Edwards Sapien 3 valve in comparison to its predecessor model (Edwards Sapien XT) in patients undergoing transfemoral aortic valve replacement. Bocksch W; Grossmann B; Geisler T; Steeg M; Droppa M; Jorbenadze R; Haap M; Gawaz M; Fateh-Moghadam S Catheter Cardiovasc Interv; 2016 Sep; 88(3):466-75. PubMed ID: 27184353 [TBL] [Abstract][Full Text] [Related]
27. 1-Year Outcomes With the Evolut R Self-Expanding Transcatheter Aortic Valve: From the International FORWARD Study. Manoharan G; Van Mieghem NM; Windecker S; Bosmans J; Bleiziffer S; Modine T; Linke A; Scholtz W; Chevalier B; Gooley R; Zeng C; Oh JK; Grube E JACC Cardiovasc Interv; 2018 Nov; 11(22):2326-2334. PubMed ID: 30466832 [TBL] [Abstract][Full Text] [Related]
28. Outcomes of Redo Transcatheter Aortic Valve Replacement for the Treatment of Postprocedural and Late Occurrence of Paravalvular Regurgitation and Transcatheter Valve Failure. Barbanti M; Webb JG; Tamburino C; Van Mieghem NM; Makkar RR; Piazza N; Latib A; Sinning JM; Won-Keun K; Bleiziffer S; Bedogni F; Kapadia S; Tchetche D; Rodés-Cabau J; Fiorina C; Nombela-Franco L; De Marco F; de Jaegere PP; Chakravarty T; Vaquerizo B; Colombo A; Svensson L; Lange R; Nickenig G; Möllmann H; Walther T; Della Rosa F; Elhmidi Y; Dvir D; Brambilla N; Immè S; Sgroi C; Gulino S; Todaro D; Pilato G; Petronio AS; Tamburino C Circ Cardiovasc Interv; 2016 Sep; 9(9):. PubMed ID: 27578840 [TBL] [Abstract][Full Text] [Related]
29. Long-Term Outcomes in Patients With New Permanent Pacemaker Implantation Following Transcatheter Aortic Valve Replacement. Chamandi C; Barbanti M; Munoz-Garcia A; Latib A; Nombela-Franco L; Gutiérrez-Ibanez E; Veiga-Fernandez G; Cheema AN; Cruz-Gonzalez I; Serra V; Tamburino C; Mangieri A; Colombo A; Jiménez-Quevedo P; Elizaga J; Laughlin G; Lee DH; Garcia Del Blanco B; Rodriguez-Gabella T; Marsal JR; Côté M; Philippon F; Rodés-Cabau J JACC Cardiovasc Interv; 2018 Feb; 11(3):301-310. PubMed ID: 29413244 [TBL] [Abstract][Full Text] [Related]
30. Outcome With the Repositionable and Retrievable Boston Scientific Lotus Valve Compared With the Balloon-Expandable Edwards Sapien 3 Valve in Patients Undergoing Transfemoral Aortic Valve Replacement. Seeger J; Gonska B; Rottbauer W; Wöhrle J Circ Cardiovasc Interv; 2017 Jun; 10(6):. PubMed ID: 28566290 [TBL] [Abstract][Full Text] [Related]
31. Axillary Transcatheter Aortic Valve Replacement in Patients With Peripheral Vascular Disease. Hysi I; Gommeaux A; Pécheux M; Hochart P; Hannebicque G; Pâris M; Manchuelle A; Fabre O Semin Thorac Cardiovasc Surg; 2019; 31(2):175-180. PubMed ID: 30291887 [TBL] [Abstract][Full Text] [Related]
32. Transfemoral aortic valve replacement with the Edwards SAPIEN and Edwards SAPIEN XT prosthesis using exclusively local anesthesia and fluoroscopic guidance: feasibility and 30-day outcomes. Durand E; Borz B; Godin M; Tron C; Litzler PY; Bessou JP; Bejar K; Fraccaro C; Sanchez-Giron C; Dacher JN; Bauer F; Cribier A; Eltchaninoff H JACC Cardiovasc Interv; 2012 May; 5(5):461-467. PubMed ID: 22560979 [TBL] [Abstract][Full Text] [Related]
33. The SAVI-TF Registry: 1-Year Outcomes of the European Post-Market Registry Using the ACURATE neo Transcatheter Heart Valve Under Real-World Conditions in 1,000 Patients. Kim WK; Hengstenberg C; Hilker M; Kerber S; Schäfer U; Rudolph T; Linke A; Franz N; Kuntze T; Nef H; Kappert U; Zembala MO; Toggweiler S; Walther T; Möllmann H JACC Cardiovasc Interv; 2018 Jul; 11(14):1368-1374. PubMed ID: 30025731 [TBL] [Abstract][Full Text] [Related]
34. A Direct Comparison of Self-Expandable Portico Versus Balloon-Expandable Sapien 3 Devices for Transcatheter Aortic Valve Replacement: A Case-Matched Cohort Study. Mas-Peiro S; Seppelt PC; Weiler H; Mohr GL; Papadopoulos N; Walther T; Zeiher AM; Fichtlscherer S; Vasa-Nicotera M J Invasive Cardiol; 2019 Jul; 31(7):E199-E204. PubMed ID: 31257214 [TBL] [Abstract][Full Text] [Related]
35. Implantation and 30-Day Follow-Up on All 4 Valve Sizes Within the Portico Transcatheter Aortic Bioprosthetic Family. Möllmann H; Linke A; Holzhey DM; Walther T; Manoharan G; Schäfer U; Heinz-Kuck K; Van Boven AJ; Redwood SR; Kovac J; Butter C; Søndergaard L; Lauten A; Schymik G; Worthley SG JACC Cardiovasc Interv; 2017 Aug; 10(15):1538-1547. PubMed ID: 28797431 [TBL] [Abstract][Full Text] [Related]
36. Safety and efficacy of a self-expanding versus a balloon-expandable bioprosthesis for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: a randomised non-inferiority trial. Lanz J; Kim WK; Walther T; Burgdorf C; Möllmann H; Linke A; Redwood S; Thilo C; Hilker M; Joner M; Thiele H; Conzelmann L; Conradi L; Kerber S; Schymik G; Prendergast B; Husser O; Stortecky S; Heg D; Jüni P; Windecker S; Pilgrim T; Lancet; 2019 Nov; 394(10209):1619-1628. PubMed ID: 31570258 [TBL] [Abstract][Full Text] [Related]